Stock ANRO ALTO NEUROSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Alto Neuroscience, Inc.

Equities

ANRO

US02157Q1094

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
11.96 USD -0.33% Intraday chart for Alto Neuroscience, Inc. -7.43% -.--%
May. 21 Alto Neuroscience, Inc. Appoints Michael Hanley as Chief Operating Officer CI
May. 14 Alto Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Stifel Initiates Alto Neuroscience With Buy Rating, Price Target is $32
MT
Baird Initiates Alto Neuroscience With Outperform Rating, Price Target is $32
MT
Jefferies Initiates Alto Neuroscience With Buy Rating, Price Target is $33
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANRO Stock
  4. News Alto Neuroscience, Inc.
  5. Analyst Reco.